Genetic and Environmental Factors in Multiple Sclerosis
Genes and Environment in Multiple Sclerosis
Recruiting
Observational Study
Multiple Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- Columbia University · Other
Who this trial is looking for
This trial is looking for people who might be at risk for multiple sclerosis due to genetics or other factors. Participants will help researchers understand these risks better, which could lead to ways to prevent or treat the disease.
Are You a Good Fit for This Trial?
You may be able to join if
- I have a family member with multiple sclerosis.
- I have received anti-TNFa therapy for other inflammatory diseases.
- I have been referred for an evaluation of new neurological symptoms.
- I live in the United States.
You may not be able to join if
- I do not match any of the inclusion criteria.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfunction in immune cells, there are genetic alterations, environmental exposures and immunologic factor…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* First Degree Relatives of Patients with MS, or
* Patients who have received anti-TNFa therapy as treatment for inflammatory diseases other than MS such as Crohn's disease, psoriasis and rheumatoid arthritis, or
* Patients that have been referred for an evaluation of first pres…
Contacts